SRP Groupe Past Earnings Performance
Past criteria checks 0/6
SRP Groupe has been growing earnings at an average annual rate of 37%, while the Specialty Retail industry saw earnings growing at 12% annually. Revenues have been growing at an average rate of 0.8% per year.
Key information
37.0%
Earnings growth rate
58.3%
EPS growth rate
| Specialty Retail Industry Growth | 14.5% |
| Revenue growth rate | 0.8% |
| Return on equity | -9.6% |
| Net Margin | -2.6% |
| Next Earnings Update | 13 Mar 2025 |
Recent past performance updates
Recent updates
Investor Optimism Abounds SRP Groupe S.A. (EPA:SRP) But Growth Is Lacking
Dec 24
Does SRP Groupe (EPA:SRP) Have A Healthy Balance Sheet?
Oct 17Investors Will Want SRP Groupe's (EPA:SRP) Growth In ROCE To Persist
Sep 12SRP Groupe S.A.'s (EPA:SRP) Shares May Have Run Too Fast Too Soon
Aug 01SRP Groupe (EPA:SRP) Has A Pretty Healthy Balance Sheet
Jun 29Should You Investigate SRP Groupe S.A. (EPA:SRP) At €1.07?
Jan 04Is SRP Groupe (EPA:SRP) Using Too Much Debt?
Sep 25Is SRP Groupe S.A. (EPA:SRP) Trading At A 28% Discount?
Jan 20The Return Trends At SRP Groupe (EPA:SRP) Look Promising
Oct 08SRP Groupe's (EPA:SRP) Returns On Capital Are Heading Higher
Jun 15SRP Groupe S.A. (EPA:SRP) Shares Fly 28% But Investors Aren't Buying For Growth
May 12Is SRP Groupe (EPA:SRP) Using Too Much Debt?
Mar 18We Like These Underlying Return On Capital Trends At SRP Groupe (EPA:SRP)
Feb 20These 4 Measures Indicate That SRP Groupe (EPA:SRP) Is Using Debt Reasonably Well
Oct 24SRP Groupe (EPA:SRP) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Mar 18Can SRP Groupe (EPA:SRP) Continue To Grow Its Returns On Capital?
Mar 15Loss-Making SRP Groupe S.A. (EPA:SRP) Set To Breakeven
Feb 16
Shareholders of SRP Groupe (EPA:SRP) Must Be Delighted With Their 324% Total Return
Jan 19Calculating The Intrinsic Value Of SRP Groupe S.A. (EPA:SRP)
Dec 24Is SRP Groupe S.A.'s (EPA:SRP) Shareholder Ownership Skewed Towards Insiders?
Nov 26Revenue & Expenses Breakdown
How SRP Groupe makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 664 | -17 | 253 | 0 |
| 31 Mar 24 | 671 | -8 | 252 | 0 |
| 31 Dec 23 | 677 | 0 | 252 | 0 |
| 30 Sep 23 | 680 | -2 | 253 | 0 |
| 30 Jun 23 | 683 | -4 | 253 | 0 |
| 31 Mar 23 | 670 | -2 | 247 | 0 |
| 31 Dec 22 | 657 | 0 | 241 | 0 |
| 30 Sep 22 | 649 | 4 | 240 | 0 |
| 30 Jun 22 | 641 | 8 | 240 | 0 |
| 31 Mar 22 | 682 | 18 | 249 | 0 |
| 31 Dec 21 | 724 | 27 | 258 | 0 |
| 30 Sep 21 | 753 | 34 | 263 | 0 |
| 30 Jun 21 | 783 | 41 | 268 | 0 |
| 31 Mar 21 | 740 | 27 | 259 | 0 |
| 31 Dec 20 | 698 | 14 | 249 | 0 |
| 30 Sep 20 | 657 | -11 | 239 | 0 |
| 30 Jun 20 | 616 | -35 | 229 | 0 |
| 31 Mar 20 | 616 | -53 | 232 | 0 |
| 31 Dec 19 | 616 | -70 | 235 | 0 |
| 30 Sep 19 | 637 | -55 | 244 | 0 |
| 30 Jun 19 | 659 | -40 | 253 | 0 |
| 31 Mar 19 | 666 | -23 | 252 | 0 |
| 31 Dec 18 | 672 | -6 | 251 | 0 |
| 30 Sep 18 | 668 | -9 | 249 | 0 |
| 30 Jun 18 | 664 | -12 | 247 | 0 |
| 31 Mar 18 | 660 | -9 | 243 | 0 |
| 31 Dec 17 | 655 | -6 | 238 | 0 |
| 30 Sep 17 | 630 | -4 | 228 | 0 |
| 30 Jun 17 | 606 | -1 | 218 | 0 |
| 31 Mar 17 | 573 | -1 | 208 | 0 |
| 31 Dec 16 | 540 | 0 | 198 | 0 |
| 30 Sep 16 | 512 | 0 | 190 | 0 |
| 30 Jun 16 | 484 | 1 | 183 | 0 |
| 31 Mar 16 | 463 | 3 | 173 | 0 |
| 31 Dec 15 | 443 | 5 | 163 | 0 |
| 30 Sep 15 | 419 | 6 | 155 | 0 |
| 30 Jun 15 | 395 | 8 | 146 | 0 |
| 31 Mar 15 | 373 | 7 | 140 | 0 |
| 31 Dec 14 | 350 | 6 | 134 | 0 |
Quality Earnings: SRP is currently unprofitable.
Growing Profit Margin: SRP is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SRP is unprofitable, but has reduced losses over the past 5 years at a rate of 37% per year.
Accelerating Growth: Unable to compare SRP's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: SRP is unprofitable, making it difficult to compare its past year earnings growth to the Specialty Retail industry (-25.1%).
Return on Equity
High ROE: SRP has a negative Return on Equity (-9.56%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/15 08:46 |
| End of Day Share Price | 2025/02/14 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
SRP Groupe S.A. is covered by 10 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Aymeric Andre Lang | Berenberg |
| Anna Patrice | Berenberg |
| Nicolas Langlet | BNP Paribas Exane |